Open Beta
MetriLume

US marketsBIIB

SEC-sourced researchBeta

BIIB

BIOGEN INC.

Company comparison ↗

Data passport

CIK
0000875045
Exchange
Nasdaq
Business activity
Biological Products, (No Diagnostic Substances) · SIC 2836
Financial inputs
6/6
Filing date
Nov 10, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 9,835,600,000.0000 USD; December 2024: 9,675,900,000.0000 USD; December 2025: 9,890,600,000.0000 USD9.9B USD0 USD0December 2023December 2024December 2025
BIIB · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20239,835,600,000.0000Feb 6, 2026
December 20249,675,900,000.0000Feb 6, 2026
December 20259,890,600,000.0000Feb 6, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20259,890,600,000.00001,292,900,000.00002,204,600,000.000029,439,500,000.000011,182,700,000.0000Feb 6, 2026
December 20249,675,900,000.00001,632,200,000.00002,875,500,000.000028,049,300,000.000011,333,300,000.0000Feb 6, 2026
December 20239,835,600,000.00001,161,100,000.00001,547,200,000.0000——Feb 6, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

77/100
Profitability76
Growth52
Balance sheet62
Cash generation95
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$9.89BJan 1, 2025 – Dec 31, 2025Feb 6, 202610-K
Previous period revenueRevenues$9.68BJan 1, 2024 – Dec 31, 2024Feb 6, 202610-K
Net incomeNetIncomeLoss$1.29BJan 1, 2025 – Dec 31, 2025Feb 6, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$2.2BJan 1, 2025 – Dec 31, 2025Feb 6, 202610-K
Total assetsAssets$29.44BDec 31, 2025Feb 6, 202610-K
Total liabilitiesLiabilities$11.18BDec 31, 2025Feb 6, 202610-K

New filings

Explore methodology ↗